🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to confirm the safety and tolerability of elra...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2021-03-22
Trial ID
NCT04798586
Treatments Being Tested
The main purpose of the study is to understand the safety and tolerability ...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2026-02-06
Trial ID
NCT07280013
Treatments Being Tested
The purpose of the study is to evaluate whether single-agent Elranatamab (P...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2021-02-02
Trial ID
NCT04649359
Treatments Being Tested
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136
The main purpose of the study is to evaluate the safety and tolerability of...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2022-12-14
Trial ID
NCT05675449
Treatments Being Tested
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-express...
Status
Recruiting
Location
Jupiter Medical Center/Anderson Family Cancer Institute
Start Date
2022-11-10
Trial ID
NCT05623020
Treatments Being Tested
The purpose of this study is to understand the study medicine (called Elran...
Status
Completed
Location
Fujian Medical University Union Hospital
Start Date
2021-12-21
Trial ID
NCT05228470
Treatments Being Tested
The purpose of the study (Part 1 and Part 2) is to evaluate the safety of a...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2021-10-07
Trial ID
NCT05014412
Treatments Being Tested
This study is to understand how well elranatamab (PF-06863135) may be used ...
Status
Completed
Location
Pfizer
Start Date
2022-10-03
Trial ID
NCT05565391
Treatments Being Tested
Provide pre-approval single-patient Expanded Access (Compassionate Use) of ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05238311
Treatments Being Tested